Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-06

Clinical Trial Update: Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combined vitrectomy with intravitreal Triamcinolone for macular edema due to branch retinal vein occlusion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Helse Stavanger HF | Conditions: Branch Retinal Vein Occlusion, Macular Edema | Phase 3 | Status: TERMINATED